WAM
PFE icon

Wolverine Asset Management’s Pfizer PFE Stock Holding History

Wolverine Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Sell
76,200
-31,000
-29% -$811K 0.02% 630
2026
Q1 		$3.01M Buy
107,200
+17,500
+20% +$466K 0.03% 460
2025
Q4 		$2.23M Sell
89,700
-68,800
-43% -$1.73M 0.02% 575
2025
Q3 		$4.04M Sell
158,500
-53,700
-25% -$1.33M 0.03% 403
2025
Q2 		$5.14M Buy
212,200
+43,500
+26% +$1.01M 0.05% 330
2025
Q1 		$4.27M Buy
168,700
+77,900
+86% +$2.04M 0.05% 332
2024
Q4 		$2.41M Buy
90,800
+36,000
+66% +$976K 0.02% 478
2024
Q3 		$1.59M Sell
54,800
-17,400
-24% -$508K 0.02% 573
2024
Q2 		$2.02M Buy
72,200
+7,200
+11% +$198K 0.02% 503
2024
Q1 		$1.8M Sell
65,000
-216,100
-77% -$6M 0.02% 519
2023
Q4 		$8.09M Buy
281,100
+103,200
+58% +$3.12M 0.07% 271
2023
Q3 		$5.9M Sell
177,900
-3,100
-2% -$110K 0.07% 283
2023
Q2 		$6.64M Sell
181,000
-11,300
-6% -$440K 0.08% 245
2023
Q1 		$7.85M Buy
192,300
+96,300
+100% +$4.16M 0.09% 241
2022
Q4 		$4.92M Buy
96,000
+93,600
+3,900% +$4.49M 0.05% 349
2022
Q3 		$105K Buy
+2,400
New +$117K ﹤0.01% 1418
2016
Q3 		– Sell
-40,895
Closed -$1.37M – 1315
2016
Q2 		$1.37M Buy
40,895
+40,486
+9,899% +$1.29M 0.02% 509
2016
Q1 		$61K Buy
+409
New +$11.7K ﹤0.01% 837
2015
Q3 		– Sell
-1,399
Closed -$3K – 1946
2015
Q2 		$3K Buy
1,399
+527
+60% +$17.2K ﹤0.01% 1727
2015
Q1 		$97K Sell
872
-226
-21% -$7.18K ﹤0.01% 1084
2014
Q4 		$199K Sell
1,098
-100
-8% -$2.87K ﹤0.01% 969
2014
Q3 		$121K Sell
1,198
-205
-15% -$5.75K ﹤0.01% 1240
2014
Q2 		$163K Buy
1,403
+1,114
+385% +$31.8K ﹤0.01% 995
2014
Q1 		$61K Buy
289
+88
+44% +$2.62K ﹤0.01% 1282
2013
Q4 		$38K Sell
201
-19
-9% -$553 ﹤0.01% 1861
2013
Q3 		$31K Sell
220
-13
-6% -$354 ﹤0.01% 1889
2013
Q2 		$39K Buy
+233
New +$6.44K ﹤0.01% 1781

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wolverine Asset Management's PFE Position: Q2 2026 in Review

Wolverine Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 22,809 shares worth $549K. The stake represents ﹤0.01% of the portfolio and ranks #925 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in PFE as recently as Q2 2025.

Wolverine Asset Management first reported a position in PFE in Q2 2013 and has held it in 37 quarters since. The position peaked at $24.1M in Q4 2015. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wolverine Asset Management held 22,809 shares of Pfizer worth $549K as of Q2 2026.
  • Pfizer was a new Wolverine Asset Management position in Q2 2026.
  • Pfizer made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #925 holding.
  • Wolverine Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 37 quarters since.
  • Wolverine Asset Management's Pfizer position peaked at $24.1M in Q4 2015.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.